Medinotec Inc.
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, … Read more
Medinotec Inc. (MDNC) - Total Liabilities
Latest total liabilities as of November 2025: $1.35 Million USD
Based on the latest financial reports, Medinotec Inc. (MDNC) has total liabilities worth $1.35 Million USD as of November 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medinotec Inc. - Total Liabilities Trend (2022–2025)
This chart illustrates how Medinotec Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medinotec Inc. Competitors by Total Liabilities
The table below lists competitors of Medinotec Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Glimpse Group Inc
NASDAQ:VRAR
|
USA | $2.20 Million |
|
Falcon Metals Limited
PINK:FALFF
|
USA | $883.21K |
|
Big Camera Corporation Public Company Limited
BK:BIG
|
Thailand | ฿1.09 Billion |
|
Daewoo SBI SPAC 1
KQ:215480
|
Korea | ₩8.10 Billion |
|
Nortech Systems Incorporated
NASDAQ:NSYS
|
USA | $41.40 Million |
|
Scope Industries Bhd
KLSE:0028
|
Malaysia | RM16.49 Million |
|
Able View Global Inc. Class B Ordinary Shares
NASDAQ:ABLV
|
USA | $29.00 Million |
|
WW GRAINGER - Dusseldorf Stock Exchang
DU:GWW
|
Germany | €5.26 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down Medinotec Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medinotec Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medinotec Inc. (2022–2025)
The table below shows the annual total liabilities of Medinotec Inc. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-02-28 | $2.54 Million | -3.75% |
| 2024-02-29 | $2.64 Million | +36.33% |
| 2023-02-28 | $1.93 Million | +7.88% |
| 2022-02-28 | $1.79 Million | -- |